These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Rational antibody-based HIV-1 vaccine design: current approaches and future directions. Walker LM; Burton DR Curr Opin Immunol; 2010 Jun; 22(3):358-66. PubMed ID: 20299194 [TBL] [Abstract][Full Text] [Related]
5. Natural infection as a blueprint for rational HIV vaccine design. van Haaren MM; van den Kerkhof TL; van Gils MJ Hum Vaccin Immunother; 2017 Jan; 13(1):229-236. PubMed ID: 27649455 [TBL] [Abstract][Full Text] [Related]
6. Rapid Induction of Multifunctional Antibodies in Rabbits and Macaques by Clade C HIV-1 CAP257 Envelopes Circulating During Epitope-Specific Neutralization Breadth Development. Malherbe DC; Wibmer CK; Nonyane M; Reed J; Sather DN; Spencer DA; Schuman JT; Guo B; Pandey S; Robins H; Park B; Fuller DH; Sacha JB; Moore PL; Hessell AJ; Haigwood NL Front Immunol; 2020; 11():984. PubMed ID: 32582155 [TBL] [Abstract][Full Text] [Related]
7. Rational design of vaccines to elicit broadly neutralizing antibodies to HIV-1. Kwong PD; Mascola JR; Nabel GJ Cold Spring Harb Perspect Med; 2011 Sep; 1(1):a007278. PubMed ID: 22229123 [TBL] [Abstract][Full Text] [Related]
8. Strategies for eliciting multiple lineages of broadly neutralizing antibodies to HIV by vaccination. Mu Z; Haynes BF; Cain DW Curr Opin Virol; 2021 Dec; 51():172-178. PubMed ID: 34742037 [TBL] [Abstract][Full Text] [Related]
9. Broadly Neutralizing Antibodies Against HIV: New Insights to Inform Vaccine Design. Sadanand S; Suscovich TJ; Alter G Annu Rev Med; 2016; 67():185-200. PubMed ID: 26565674 [TBL] [Abstract][Full Text] [Related]
10. Broadly neutralizing antibodies: What is needed to move from a rare event in HIV-1 infection to vaccine efficacy? Subbaraman H; Schanz M; Trkola A Retrovirology; 2018 Jul; 15(1):52. PubMed ID: 30055627 [TBL] [Abstract][Full Text] [Related]
11. Strategies for a multi-stage neutralizing antibody-based HIV vaccine. Andrabi R; Bhiman JN; Burton DR Curr Opin Immunol; 2018 Aug; 53():143-151. PubMed ID: 29775847 [TBL] [Abstract][Full Text] [Related]
12. Virological features associated with the development of broadly neutralizing antibodies to HIV-1. Moore PL; Williamson C; Morris L Trends Microbiol; 2015 Apr; 23(4):204-11. PubMed ID: 25572881 [TBL] [Abstract][Full Text] [Related]
13. HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman Primates. Wang Y; O'Dell S; Turner HL; Chiang CI; Lei L; Guenaga J; Wilson R; Martinez-Murillo P; Doria-Rose N; Ward AB; Mascola JR; Wyatt RT; Karlsson Hedestam GB; Li Y J Virol; 2017 Nov; 91(21):. PubMed ID: 28835491 [TBL] [Abstract][Full Text] [Related]
14. DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titers. Gupta S; Clark ES; Termini JM; Boucher J; Kanagavelu S; LeBranche CC; Abraham S; Montefiori DC; Khan WN; Stone GW J Virol; 2015 Apr; 89(8):4158-69. PubMed ID: 25631080 [TBL] [Abstract][Full Text] [Related]
15. Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies. Ahmed Y; Tian M; Gao Y AIDS Res Ther; 2017 Sep; 14(1):50. PubMed ID: 28893278 [TBL] [Abstract][Full Text] [Related]
16. Coadministration of CH31 Broadly Neutralizing Antibody Does Not Affect Development of Vaccine-Induced Anti-HIV-1 Envelope Antibody Responses in Infant Rhesus Macaques. Dennis M; Eudailey J; Pollara J; McMillan AS; Cronin KD; Saha PT; Curtis AD; Hudgens MG; Fouda GG; Ferrari G; Alam M; Van Rompay KKA; De Paris K; Permar S; Shen X J Virol; 2019 Mar; 93(5):. PubMed ID: 30541851 [TBL] [Abstract][Full Text] [Related]
17. Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers. Landais E; Moore PL Retrovirology; 2018 Sep; 15(1):61. PubMed ID: 30185183 [TBL] [Abstract][Full Text] [Related]
18. Positive Selection at Key Residues in the HIV Envelope Distinguishes Broad and Strain-Specific Plasma Neutralizing Antibodies. Mabvakure BM; Scheepers C; Garrett N; Abdool Karim S; Williamson C; Morris L; Moore PL J Virol; 2019 Mar; 93(6):. PubMed ID: 30567996 [TBL] [Abstract][Full Text] [Related]
20. Catch Me If You Can--The Race Between HIV and Neutralizing Antibodies. Geiß Y; Dietrich U AIDS Rev; 2015; 17(2):107-13. PubMed ID: 26035168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]